DiaSorin LIAISON HSV-2 Type Specific IgG recall
DiaSorin LIAISON HSV-2 Type Specific IgG, REF 310620
Why was DiaSorin LIAISON HSV-2 Type Specific IgG recalled?
DiaSorin has identified that lots 136344, 136344A, 136344B, 136344C, 136520, 136520A, 136520B, 136520C, 136604, 136703, 136703A, 136703B, 136703C 136775of LIAISON HSV-2 Type Specific IgG assay may produce increased equivocal and/or false positive results.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
UDI/DI 08056771600101, Lot Numbers: 136344, 136344A, 136344B, 136344C, 136520, 136520A, 136520B, 136520C, 136604, 136703, 136703A, 136703B, 136703C, 136775
- Product
- DiaSorin LIAISON HSV-2 Type Specific IgG, REF 310620
- Recalling firm
- Diasorin Inc.
- Quantity
- 31992 units
- Distribution
- Worldwide distribution - US Nationwide and the country of Canada.
- Recall date
- January 31, 2024
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (device)